- The partnership – Rhapsody Envoy Edge by M42 – aims to streamline data exchange, providing healthcare organizations with easy access to scalable, interoperable solutions worldwide
- Groundbreaking collaboration leverages robust cloud capabilities and technological advancements to improve workflow efficiency and patient-centric care
Dubai, UAE, 27 January 2025: Global health leader M42, which is powered by artificial intelligence (AI) and technology, has announced a groundbreaking partnership with Rhapsody, a leading digital health enablement platform, to empower precision medicine initiatives across the UAE and beyond. This collaboration, powered by Microsoft Azure, aims to redefine healthcare data integration and enhance global health outcomes by delivering cutting-edge solutions for seamless and scalable interoperability. The announcement was made on day one of Arab Health 2025.
By addressing the demand for streamlined and interoperable systems, the new partnership – Rhapsody Envoy Edge by M42 – will leverage the robust infrastructure of Microsoft Azure, enabling broader access and scalability for healthcare organizations worldwide. Its innovative solutions will empower healthcare providers to exchange data effortlessly, enhance patient outcomes and drive operational efficiency. The platform will soon be available on the Microsoft Azure Marketplace.
“Rhapsody Envoy Edge by M42 marks a pivotal moment as we continue to push the boundaries of healthcare innovation. By leveraging the powerful capabilities of Microsoft Azure and combining technological innovation, interoperability expertise and a commitment to patient-centric solutions, the collaboration has the potential to transform how healthcare providers operate. Our combined expertise will drive significant improvements in data exchange and integration, operational efficiency, and ultimately patient outcomes, to create an efficient global healthcare ecosystem,” said Khalid Al Amadi, Chief Information Officer, Global Patient Care, M42.
Key highlights of the partnership include:
- Improving healthcare interoperability: By combining M42’s deep expertise in healthcare and life sciences with Rhapsody’s best-in-class healthcare integration knowledge and capabilities, this partnership will simplify data exchange, optimize workflows, and enable healthcare systems to focus on patient care.
- Powered by Microsoft Azure: The Rhapsody market-leading health data integration platform will be hosted on Microsoft Azure, ensuring enhanced security, reliability and scalability for global healthcare providers.
- Available on Microsoft Marketplace: The upcoming launch of Rhapsody Envoy Edge by M42 on Microsoft Azure Marketplace will provide healthcare organizations with easy access to powerful tools that support interoperability, accelerating digital transformation in healthcare worldwide.
“We’ve built a strong partnership with both M42 and Microsoft, aligned on our shared vision of accelerating the adoption of digital health innovation. Rhapsody Envoy Edge by M42 will make it easier, more efficient, and more effective for healthcare providers to access usable data that is needed to deliver better, more informed patient care,” stated Stuart Heavyside, Chief Revenue Officer of Rhapsody.
Arab Health attendees can visit the M42 booth located in Hall 6 – Gold Zone, Stand B30, to learn more about M42’s initiatives, groundbreaking healthcare solutions and collaborative opportunities.
About M42
M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally.
Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi.
About Rhapsody
Rhapsody is a digital health enablement platform company with healthcare integration, identity management, and clinical terminology solutions. Rhapsody enables over 1,700 teams, including care providers, health tech builders, and public health, around the globe to save time, reduce costs, and speed time to value by accelerating the adoption of digital health innovation through interoperability. Rhapsody API-enabled solutions are flexible to meet customers where they are, deployable in a private cloud or a Rhapsody cloud.